| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 103.919 | 76 |
| GSM780708 | Untreated after 4 days (C2_1) | 80.2011 | 72 |
| GSM780709 | Untreated after 4 days (C3_1) | 85.3408 | 73 |
| GSM780719 | Untreated after 4 days (C1_2) | 128.895 | 79 |
| GSM780720 | Untreated after 4 days (C2_2) | 70.0387 | 69 |
| GSM780721 | Untreated after 4 days (C3_2) | 78.3253 | 71 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 70.1708 | 69 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 91.9303 | 74 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 124.395 | 78 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 78.6863 | 71 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 79.3753 | 72 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 109.708 | 77 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 115.941 | 77 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 110.416 | 77 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 94.3949 | 74 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 137.51 | 79 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 115.571 | 77 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 101.657 | 75 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 66.9291 | 68 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 109.375 | 76 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 93.9095 | 74 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 102.242 | 76 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 78.4353 | 71 |